PhRMA member companies share how they are improving clinical trial diversity
By Dr. Freda Lewis-Hall | April 14, 2021
As part of the biopharmaceutical industry’s efforts to improve health outcomes for patients in underserved communities, PhRMA member companies are identifying ways to improve clinical trial...
Read More
Our three-part approach to build a better health care system
By Stephen J. Ubl | April 13, 2021
On April 3, more than four million Americans received a COVID-19 vaccine — the largest single-day vaccination event in human history. For innovators across the pharmaceutical industry, these...
Read More
ICYMI: New CBO Report highlights biopharmaceutical leadership in the development of new treatments and cures
By Andrew Powaleny | April 12, 2021
America’s biopharmaceutical companies are at the heart of a research and development (R&D) ecosystem that develops more innovative medicines than any other country in the world. The ongoing...
Read More
Diversifying clinical trials and fighting disease requires equity and trust
By Rebecca Marklund | April 12, 2021
The COVID-19 pandemic has left no person unaffected, but Black Americans have been disproportionately impacted. Black adults are nearly four times more likely to be hospitalized from the virus and...
Read More
Key excerpts: PhRMA submits comments to NIST in effort to safeguard intellectual property protections
By Megan Van Etten | April 9, 2021
Earlier this week PhRMA submitted comments to the National Institute of Standards and Technology (NIST) regarding the proposed rulemaking on implementing regulations of the Bayh-Dole Act. Passed...
Read More
Strengthening a culture dedicated to patients and equity: A conversation with Vas Narasimhan, CEO of Novartis
By Stephen J. Ubl | March 31, 2021
This year our industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections....
Read More
Data shows that keeping a strong biopharmaceutical industry is important to Americans
By Mark Keida | March 30, 2021
The United States biopharmaceutical industry continues to innovate and discover critical solutions for our toughest health challenges such as the COVID-19 pandemic. America’s global leadership has...
Read More
New report demonstrates the growing importance of partnerships in advancing biomedical innovation
By Abigail Lore | March 24, 2021
As we mark a full year since COVID-19 was declared a global pandemic, it’s impossible to overstate the significance of collaborations. The unprecedented level of strategic collaborative efforts...
Read More
Cross-country comparisons of medicine prices are like comparing apples to oranges
By Nicole Longo | March 22, 2021
Looking at differences in medicine prices between the United States and other countries can be misleading, often ignoring the complexities in the U.S. system and the repercussions of other...
Read More
Building confidence in the COVID-19 vaccine through education
By Megan Van Etten | March 22, 2021
Throughout the COVID-19 vaccine research and development process, the biopharmaceutical industry has worked to uphold the highest standards of research, clinical testing and manufacturing.
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
